(Q39999207)

16 September 2017

title

Cardiovascular risk factors in adult Malawians on long-term antiretroviral therapy (English)

1 reference

16 September 2017

main subject

anti-retroviral agent

0 references

1 reference

William Muronya

1

1 reference

16 September 2017

Esther Sanga

2

1 reference

16 September 2017

George Talama

3

1 reference

16 September 2017

Johnstone J Kumwenda

4

1 reference

16 September 2017

Joep J van Oosterhout

5

1 reference

16 September 2017

publication date

15 September 2011

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

16 September 2017

published in

1 reference

16 September 2017

volume

105

1 reference

16 September 2017

issue

11

1 reference

16 September 2017

page(s)

644-649

1 reference

Scaling up antiretroviral treatment in resource-poor settings

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.07.016

Malawi's contribution to "3 by 5": achievements and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.07.016

The survival benefits of AIDS treatment in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.07.016

Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.07.016

Combination antiretroviral therapy and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.07.016

Myocardial infarction risk in HIV-infected patients: epidemiology, pathogenesis, and clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.07.016

CD4+ count-guided interruption of antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.07.016

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.07.016

Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.07.016

Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.07.016

Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.07.016

Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.07.016

The burden of selected chronic non-communicable diseases and their risk factors in Malawi: nationwide STEPS survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.07.016

Metabolic function and the prevalence of lipodystrophy in a population of HIV-infected African subjects receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.07.016

Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4- to 9-year antiretroviral therapy in Senegal: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.07.016

Blood cholesterol screening influence of fasting state on cholesterol results and management decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.07.016

Protease inhibitors and cardiovascular outcomes in patients with HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.07.016

Cardiovascular Risks of Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.07.016

10.1016/J.TRSTMH.2011.07.016

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference